Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
5
×
Tags
biotech
boston blog main
boston top stories
life sciences
national blog main
5
×
national top stories
san francisco blog main
san francisco top stories
5
×
clinical trials
eli lilly
fda
indiana blog main
indiana top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
amgen
avapritinib
blueprint medicines
boston
calcitonin gene-related peptide
eptinezumab
erenumab
fremanezumab
galcanezumab
genentech
medullary thyroid cancer
What
approval
5
×
drug
fda
5
×
medicines
won
blueprint
cancer
class
developed
migraine
new
oral
ret
therapy
address
agency
aimmune
allergy
amgen
approved
approves
arguments
awarded
big
candidate
candidates
carries
certain
commercialized
companies
competitors
currently
decades
designed
drugs
friday
genetic
gets
head
immunotherapy
Language
unset
Current search:
photo
×
fda
×
" san francisco top stories "
×
" national blog main "
×
approval
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines